• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Drug developed in Cambridge approved for treatment of multiple sclerosis

Drug developed in Cambridge approved for treatment of multiple sclerosis

Drug developed in Cambridge approved for treatment of multiple sclerosis

Published on 20 September, 2013

Approval concludes nearly 40-year epic journey from fundamental research, begun at LMB, to discovery of an effective treatment for active relapsing multiple sclerosis. More…

2013 César Milstein Lecture to be given by Scott Emr

Published on 20 September, 2013

Professor Scott Emr will give the 2013 Milstein Lecture on Thursday 26 September at 4.15pm in the LMB’s Max Perutz Lecture Theatre. The lecture, entitled “Sorting out protein traffic: Ubiquitin-mediated endocytosis and a membrane protein’s final ESCRT”, is open to anyone in the local area who is interested in attending. Scott is currently Professor of […]

Novel technology useful for development of gene and drug therapies licensed to local company

Published on 10 September, 2013

A method for parallel assembly of a large number of peptide-therapeutic cargo combinations, developed by Mike Gait’s group in the LMB’s PNAC Division, has been licensed to Cambridge Research Biochemicals (CRB). The company aims to launch a service in October to provide both researchers and pharmaceutical companies with custom-made libraries of peptide-cargo conjugates to help […]

Monoclonal antibodies; from their debut to blockbuster status

Published on 15 August, 2013

They’re found in home-testing kits for pregnancy, hospital tests for MRSA, and in six out of ten of the best-selling drugs today. But monoclonal antibodies have kept a surprisingly low profile since their debut in a Nature paper in 1975. This podcast follows them from that time through patent wars, promising drug trials and finally […]

Hugh Huxley – 25th February 1924 – 25th July 2013

Published on 26 July, 2013

It is with great sadness that we report that Hugh Huxley died yesterday following a major heart attack on Monday at his home with Frances in Woods Hole. Hugh was the very first Ph.D. student to join the MRC Unit for the Study of the Molecular Structure of Biological Systems in 1948 under the leadership […]

Vesicles modulate an actin network for asymmetric spindle positioning in oocytes

Published on 22 July, 2013

Work carried out by Melina Schuh’s group in the LMB’s Cell Biology Division has provided new insights into how the spindle is asymmetrically positioned in oocytes, which is a vital step in the development of a fertilizable egg in mammals. The oocyte is stored in the ovary in meiotic arrest until ovulation. At ovulation, the […]

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 271
  • Page 272
  • Page 273
  • Page 274
  • Page 275
  • Interim pages omitted …
  • Page 327
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.